Bobo Donald E Jr's Form 4 filing
Edwards Lifesciences Corp (EW) · filed Jan 31, 2022
- Accession no.
- 0001225208-22-001213
- Filed
- Jan 31, 2022
- Trade date
- Dec 22, 2021-Jan 28, 2022
- Filing delay
- 40 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.12M. It was filed 40 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bobo Donald E JrCIK 0001196661 | Officer (CVP,Strategy/Corp Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2021 | Common Stock | GGiftAcquired | +1,000 | $0.00 | $0 | 57,399.4 | Direct | |
| Jan 28, 2022 | Common Stock | MOption exerciseAcquired | +11,050 | $21.76 | +$240,448 | 68,449.4 | Direct | |
| Jan 28, 2022 | Common Stock | SSaleDisposed | −500 | $98.23F3 | −$49,115 | 67,949.4 | Direct | |
| Jan 28, 2022 | Common Stock | SSaleDisposed | −700 | $99.54F4 | −$69,678 | 67,249.4 | Direct | |
| Jan 28, 2022 | Common Stock | SSaleDisposed | −2,700 | $101.73F5 | −$274,671 | 64,549.4 | Direct | |
| Jan 28, 2022 | Common Stock | SSaleDisposed | −3,058 | $102.41F6 | −$313,169.78 | 61,491.4 | Direct | |
| Jan 28, 2022 | Common Stock | SSaleDisposed | −4,092 | $100.45F7 | −$411,041.4 | 57,399.4 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2022 | Common Stock | MOption exerciseDisposed | −11,050 | $0.00 | $0 | 33,150 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This transaction was executed in multiple trades at prices ranging from $97.730 to $98.360. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $99.070 to $100.000 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $101.340 to $102.190. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $102.340 to $102.655. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $100.090 to $100.970. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.